These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2896642)

  • 1. Controlled study of extrapyramidal reactions in the management of delirious, medically ill patients: intravenous haloperidol versus intravenous haloperidol plus benzodiazepines.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    Heart Lung; 1988 May; 17(3):238-41. PubMed ID: 2896642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased extrapyramidal symptoms with intravenous haloperidol.
    Menza MA; Murray GB; Holmes VF; Rafuls WA
    J Clin Psychiatry; 1987 Jul; 48(7):278-80. PubMed ID: 3597329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of delirium in the critically ill patient.
    Fish DN
    Clin Pharm; 1991 Jun; 10(6):456-66. PubMed ID: 1676622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergency intravenous sedation of the delirious, medically ill patient.
    Adams F
    J Clin Psychiatry; 1988 Dec; 49 Suppl():22-7. PubMed ID: 2461929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extrapyramidal side effects and oral haloperidol: an analysis of explanatory patient and treatment characteristics.
    Moleman P; Schmitz PJ; Ladee GA
    J Clin Psychiatry; 1982 Dec; 43(12):492-6. PubMed ID: 7161250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Olanzapine vs haloperidol: treating delirium in a critical care setting.
    Skrobik YK; Bergeron N; Dumont M; Gottfried SB
    Intensive Care Med; 2004 Mar; 30(3):444-9. PubMed ID: 14685663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of the corrected QT and torsades de pointes cardiac arrhythmia associated with intravenous haloperidol in the medically ill.
    Metzger E; Friedman R
    J Clin Psychopharmacol; 1993 Apr; 13(2):128-32. PubMed ID: 8463445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptom-driven lorazepam protocol for treatment of severe alcohol withdrawal delirium in the intensive care unit.
    DeCarolis DD; Rice KL; Ho L; Willenbring ML; Cassaro S
    Pharmacotherapy; 2007 Apr; 27(4):510-8. PubMed ID: 17381377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S; Milajerdi MR; Amini H; Tehrani-Doost M
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of delirium associated with use of the intra-aortic balloon pump.
    Sanders KM; Stern TA
    Am J Crit Care; 1993 Sep; 2(5):371-7. PubMed ID: 8220668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of common symptoms in terminally ill patients: Part II. Constipation, delirium and dyspnea.
    Ross DD; Alexander CS
    Am Fam Physician; 2001 Sep; 64(6):1019-26. PubMed ID: 11578023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of severe, refractory agitation with a haloperidol drip.
    Fernandez F; Holmes VF; Adams F; Kavanaugh JJ
    J Clin Psychiatry; 1988 Jun; 49(6):239-41. PubMed ID: 3379030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement disorders in patients treated with long-acting injectable antipsychotic drugs.
    Bransgrove LL; Kelly MW
    Am J Hosp Pharm; 1994 Apr; 51(7):895-9. PubMed ID: 7912473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Lorazepam With Haloperidol vs Haloperidol Alone on Agitated Delirium in Patients With Advanced Cancer Receiving Palliative Care: A Randomized Clinical Trial.
    Hui D; Frisbee-Hume S; Wilson A; Dibaj SS; Nguyen T; De La Cruz M; Walker P; Zhukovsky DS; Delgado-Guay M; Vidal M; Epner D; Reddy A; Tanco K; Williams J; Hall S; Liu D; Hess K; Amin S; Breitbart W; Bruera E
    JAMA; 2017 Sep; 318(11):1047-1056. PubMed ID: 28975307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective, randomized, controlled trial of benzodiazepines and nitroglycerine or nitroglycerine alone in the treatment of cocaine-associated acute coronary syndromes.
    Honderick T; Williams D; Seaberg D; Wears R
    Am J Emerg Med; 2003 Jan; 21(1):39-42. PubMed ID: 12563578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of nefazodone in the treatment of neuroleptic induced extrapyramidal side effects: a double-blind randomised parallel group placebo-controlled trial.
    Wynchank D; Berk M
    Hum Psychopharmacol; 2003 Jun; 18(4):271-5. PubMed ID: 12766931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acute neuroleptic-induced movement disorders.
    Tonda ME; Guthrie SK
    Pharmacotherapy; 1994; 14(5):543-60. PubMed ID: 7997388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.